Latest News about Chardan Capital Markets
Recent news which mentions Chardan Capital Markets
Straight Path Crossed: Speculative Short To M&A Darling, A Look Back At StraightPath Communications Journey
May 08, 2017
From Benzinga
From Benzinga
4 Reasons Why 2017 Will Be A Pivotal Year For Vuzix
March 20, 2017
From Benzinga
Vuzix's Accelerated Sales Ramp Should Continue In 2017
March 17, 2017
From Benzinga
Clovis Shares Reiterated As A Sell Following 10% Rally
March 15, 2017
From Benzinga
Chardan Analyst Suggests An AveXis-Ionis Pair Trade
February 06, 2017
From Benzinga
Social Reality Wins A Buy Rating, $9 Price Target From Chardan
February 01, 2017
Tickers
SRAX
From Benzinga
From Benzinga
Despite Guidance Miss, Teladoc Still Attractive
January 09, 2017
From Benzinga
5 Key Takeaways In Regeneron's Praluent Suit, Steps Forward
January 06, 2017
From Benzinga
The Medicines Company Is A Top Pick For 2017
January 06, 2017
From Benzinga
Reasons To Stay Bullish On Alnylam In The New Year
December 19, 2016
From Benzinga
For Arbutus' Hepatitis B Treatment, 'Liver Safety Risk Overwhelms Promising Efficacy'
December 13, 2016
From Benzinga
Chardan Upgrades Regeneron; Cites Fovista Failure, Stock's Recent Underperformance
December 12, 2016
From Benzinga
From Benzinga
Chardan: Watch Wearable Maker Vuzix Into CES
December 05, 2016
From Benzinga
Alnylam Is Now The Leader In The Clinical HBV RNAi Therapy Space
November 30, 2016
From Benzinga
Arrowhead Pharma Downgraded Following EX-1 RNAi Program Discontinuations
November 29, 2016
Tickers
ARWR
From Benzinga
Amicus Therapeutics: Here's The Good News
November 29, 2016
From Benzinga
3 Turnaround Stories Getting Love From Sell-Side Analysts
August 09, 2016
From Benzinga
Chardan Analyst Believe iPass' Turnaround Strategy Is Working
August 04, 2016
Tickers
IPAS
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.